

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | — | — | — | — | 1 |
| Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
| Ovarian epithelial carcinoma | D000077216 | — | — | 1 | — | — | — | — | 1 |
| Drug common name | ELIMUSERTIB |
| INN | elimusertib |
| Description | Elimusertib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target serine/threonine-protein kinase ATR. |
| Classification | Small molecule |
| Drug class | serine/threonine kinase inhibitors |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccn[nH]3)c2n1 |
| PDB | — |
| CAS-ID | 1876467-74-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL4647810 |
| ChEBI ID | — |
| PubChem CID | 118869362 |
| DrugBank | DB19041 |
| UNII ID | 7N13IK9LNH (ChemIDplus, GSRS) |
